MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 24 filers reported holding MOLECULIN BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,708 | -26.1% | 6,334 | 0.0% | 0.00% | – |
| Q2 2023 | $3,666 | -39.7% | 6,334 | 0.0% | 0.00% | – |
| Q1 2023 | $6,081 | -9.5% | 6,334 | -0.1% | 0.00% | – |
| Q4 2022 | $6,719 | +12.0% | 6,339 | +5.4% | 0.00% | – |
| Q3 2022 | $6,000 | -33.3% | 6,012 | +0.2% | 0.00% | – |
| Q2 2022 | $9,000 | -18.2% | 6,000 | -0.4% | 0.00% | – |
| Q1 2022 | $11,000 | 0.0% | 6,025 | +0.4% | 0.00% | – |
| Q4 2021 | $11,000 | -38.9% | 6,001 | +0.0% | 0.00% | – |
| Q3 2021 | $18,000 | -50.0% | 6,000 | -38.2% | 0.00% | – |
| Q2 2021 | $36,000 | -7.7% | 9,713 | 0.0% | 0.00% | – |
| Q1 2021 | $39,000 | – | 9,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,040,529 | $1,852,000 | 0.61% |
| Sigma Planning Corp | 57,500 | $102,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 4,233 | $7,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6,650 | $12,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,176 | $7,000 | 0.00% |
| NORTHERN TRUST CORP | 50,731 | $90,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 245,612 | $437,000 | 0.00% |
| STATE STREET CORP | 71,397 | $127,000 | 0.00% |
| North Star Investment Management Corp. | 250 | $0 | 0.00% |